[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617169":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":45,"collaborators":47,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":71,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study population",null,"Single-arm study including 510 patients meeting identical inclusion and exclusion criteria and receiving the same intervention. All participants are enrolled in one study group. Subgroup analyses according to Fitzpatrick skin phototype are planned and are described in the Detailed Description section.",[13],"Procedure: Skin color assessment",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Skin color assessment","Each participant's skin color is evaluated according to the Fitzpatrick skin type classification. All other care is standard, and no additional treatment is administered.",[9],[21,27],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},"Harmony PLACERDAT","CONTACT","07 61 67 30 15","+33","harmony.placerdat@aphp.fr",{"name":28,"role":23,"phone":10,"phoneExt":10,"email":29},"Aline DECHANET","aline.dechanet@aphp.fr",[31],{"facility":32,"status":10,"city":33,"state":10,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Maternité Port Royal","Paris","75014","France","FR",{"type":38,"coordinates":39},"Point",[40,41],2.3488,48.85341,{"lat":41,"lon":40},[44],{"name":22,"role":23,"phone":24,"phoneExt":25,"email":26},{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[48],{"name":49,"class":6},"URC-CIC Paris Descartes Necker Cochin","100617169","reliability-of-transcutaneous-bilirubin-measurement-according-to-the-skin-colour-of-newborns-100617169",false,"NCT07315126","Reliability of Transcutaneous Bilirubin Measurement According to the Skin Colour of Newborns","BILICOLOR","Inclusion Criteria:\n\n* Born from 36 weeks of amenorrhea\n* Hospitalized in the postnatal ward or kangaroo care unit\n* Requiring a blood test for bilirubin analysed at the Cochin laboratory.\n* No objection from both holders of parental authority.\n\nExclusion Criteria:\n\n* Having received phototherapy treatment within the last 24 hours","ALL","1 Hour","7 Days",{"count":61,"type":62},510,"ESTIMATED","OBSERVATIONAL","Neonatal jaundice is a physiological process characterized by a yellow coloration of the skin and mucous membranes linked to an increase in a pigment: bilirubin. However, an excessive accumulation of bilirubin can lead to neurological complications: kernicterus. The screening for pathological jaundice is carried out through daily measurements of transcutaneous bilirubin using non-invasive devices (bilirubinometers). The diagnosis is made by measuring blood bilirubin levels and comparing them with reference curves. In newborns with dark skin, transcutaneous bilirubin measurements may be inaccurate because melanin interferes with the bilirubinometers.",[66],"Neonatal Jaundice",[68,69,70],"Neonatal jaundice","Kernicterus","Newborn","NOT_YET_RECRUITING","2025-12-17",{"date":74,"type":75},"2026-01-02","ACTUAL",{"date":77,"type":62},"2026-03",{"date":79,"type":62},"2027-04",{"name":5,"class":6},1]